Results 1 to 10 of about 31,788 (164)

Tumor Heterogeneity in VHL Drives Metastasis in Clear Cell Renal Cell Carcinoma

open access: yesSignal Transduction and Targeted Therapy, 2023
Loss of function of the von Hippel-Lindau (VHL) tumor suppressor gene is a hallmark of clear cell renal cell carcinoma (ccRCC). The importance of heterogeneity in the loss of this tumor suppressor has been under reported.
Junhui Hu, Hua Xu
exaly   +2 more sources

Hereditary Renal Cell Carcinoma: Is Age an Independent Criterion for Genetic Testing? A Large Cohort from a Latin America Referral Center

open access: yesJournal of Kidney Cancer and VHL, 2023
Although age younger than 46 years has been an independent criterion for genetic testing in hereditary renal cell carcinoma (hRCC), there is a lack of evidence in the literature.
Tomás Carminatti   +6 more
doaj   +3 more sources

Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians

open access: yesAsian Journal of Urology, 2022
Objective: The aim of the current review is to summarize the available evidence to aid clinicians in the surveillance, treatment and follow-up of the different primary tumors developed by patients diagnosed with von Hippel-Lindau (VHL) syndrome. Methods:
Alessandro Larcher   +24 more
doaj   +1 more source

Loss of one copy of vhl in zebrafish facilitates hypoxia tolerance

open access: yesAquaculture Reports, 2023
Insufficient oxygen in the water (hypoxia) is one of the limiting factors for high-density culture in modern aquaculture. Hypoxia tolerance in fish has been reported to be related to the hypoxia-inducible factor (HIF)-α-mediated hypoxia signaling pathway.
Xueyi Sun   +8 more
doaj   +1 more source

Exploiting the circuit breaker cancer evolution model in human clear cell renal cell carcinoma

open access: yesCell Stress, 2020
The incessant interactions between susceptible humans and their respective macro/microenvironments registered throughout their lifetime result in the ultimate manifestation of individual cancers.
James J. Hsieh, Emily H. Cheng
doaj   +1 more source

Hereditary Renal Cell Carcinoma Syndromes

open access: yesSociété Internationale d’Urologie Journal, 2022
A number of germline syndromes that predispose affected individuals to develop renal cancer have been described, each with unique manifestations, histopathology, and tumor behavior.
Jodie K. Maranchie   +3 more
doaj   +1 more source

The relationship between RSUME and VHL/HIF-1α signalling pathway in renal cell carcinoma

open access: yesArchives of Medical Science, 2020
Introduction Renal cell carcinoma (RCC) is characterised by loss of the von Hippel-Lindau tumour suppressor gene (VHL), and the functional tumourigenic consequences of this loss have been used to develop therapies for advanced renal cell carcinoma, such ...
Yuanliang Wang   +9 more
doaj   +1 more source

An affinity-directed protein missile system for targeted proteolysis [PDF]

open access: yesOpen Biology, 2016
The von Hippel–Lindau (VHL) protein serves to recruit the hypoxia-inducible factor alpha (HIF1α) protein under normoxia to the CUL2 E3 ubiquitin ligase for its ubiquitylation and degradation through the proteasome.
Luke J. Fulcher   +5 more
doaj   +1 more source

Visual prognosis based staging for retinal capillary hemangioma

open access: yesРоссийский офтальмологический журнал, 2020
Purpose. To analyze the literature to determine the visual prognosis of eyes affected by retinal angiomatosis of Von-Hippel Lindau disease (VHL). Study Type. Retrospective literature analysis. Methods.
G. Garg, P. T. Finger
doaj   +1 more source

Germline genetic variants in pheochromocytoma/paraganglioma: single-center experience

open access: yesEndocrine Oncology, 2023
Pheochromocytoma and paragangliomas (PPGLs) are rare neuroendocrine tumors carrying 25–40% pathogenic germline gene variants (PGVs). We evaluated clinical, laboratory, and germline molecular profile of 115 patients with pathologic (14 patients were ...
José V Lima Jr   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy